These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12632879)

  • 1. Putting the costs of prescription drugs in perspective for Medicare beneficiaries.
    Moon M
    Care Manag J; 2002; 3(3):126-34. PubMed ID: 12632879
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of Medicare Part D on prescription drug use by the elderly.
    Lichtenberg FR; Sun SX
    Health Aff (Millwood); 2007; 26(6):1735-44. PubMed ID: 17978393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Who will be denied Medicare prescription drug subsidies because of the asset test?
    Rice T; Desmond K
    Am J Manag Care; 2006 Jan; 12(1):46-54. PubMed ID: 16402888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. By the numbers. The rising costs of prescription drugs.
    Thornton D
    Healthplan; 1999; 40(5):71-2. PubMed ID: 10622972
    [No Abstract]   [Full Text] [Related]  

  • 5. Medicare beneficiaries and drug coverage.
    Poisal JA; Chulis GS
    Health Aff (Millwood); 2000; 19(2):248-56. PubMed ID: 10718039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can Medicare beneficiaries pay outpatient drug bills?
    Grimaldi PL
    Nurs Manage; 2000 Jan; 31(1):11-2. PubMed ID: 10818932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients.
    Tseng CW; Brook RH; Keeler E; Mangione CM
    JAMA; 2003 Jul; 290(2):222-7. PubMed ID: 12851277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High out-of-pocket health care spending by the elderly.
    Goldman DP; Zissimopoulos JM
    Health Aff (Millwood); 2003; 22(3):194-202. PubMed ID: 12757285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A first look at the new Medicare prescription drug plans.
    Frakt AB; Pizer SD
    Health Aff (Millwood); 2006; 25(4):W252-61. PubMed ID: 16720588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of prescription drug benefit may help Medicare beneficiaries budget prescription drug costs more effectively.
    Find Brief; 2001 Oct; 4(5):1-3. PubMed ID: 12138926
    [No Abstract]   [Full Text] [Related]  

  • 11. Prescription drugs: issues of cost, coverage, and quality.
    Copeland C
    EBRI Issue Brief; 1999 Apr; (208):1-21. PubMed ID: 10539445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicare prescription drug coverage gap: navigating the "doughnut hole" with patients.
    Berkowitz SA; Gerstenblith G; Anderson GF
    JAMA; 2007 Feb; 297(8):868-70. PubMed ID: 17327528
    [No Abstract]   [Full Text] [Related]  

  • 13. The prescription-drug problem.
    Steinbrook R
    N Engl J Med; 2002 Mar; 346(11):790. PubMed ID: 11893789
    [No Abstract]   [Full Text] [Related]  

  • 14. The implications of a Medicare prescription drug benefit.
    Manag Care Interface; 2000 May; 13(5):44-5. PubMed ID: 11067393
    [No Abstract]   [Full Text] [Related]  

  • 15. Insurance coverage for prescription drugs: effects on use and expenditures in the Medicare population.
    Lillard LA; Rogowski J; Kington R
    Med Care; 1999 Sep; 37(9):926-36. PubMed ID: 10493470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The new Medicare Part D prescription drug benefit: an estimation of its effect on prescription drug costs in a Medicare population with atrial fibrillation.
    Evans-Molina C; Regan S; Henault LE; Hylek EM; Schwartz GR
    J Am Geriatr Soc; 2007 Jul; 55(7):1038-43. PubMed ID: 17608876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compliance among pharmacies in California with a prescription-drug discount program for Medicare beneficiaries.
    Lewis JH; Schonlau M; Muñoz JA; Asch SM; Rosen MR; Yang H; Escarce JJ
    N Engl J Med; 2002 Mar; 346(11):830-5. PubMed ID: 11893795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans.
    Patel UD; Davis MM
    J Am Soc Nephrol; 2006 Sep; 17(9):2546-53. PubMed ID: 16855016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescription drugs: recent trends in utilization, expenditures, and coverage.
    Sethi RC
    EBRI Issue Brief; 2004 Jan; (265):1-35. PubMed ID: 14969223
    [No Abstract]   [Full Text] [Related]  

  • 20. Changing prescription drug sector: new expenditure methodologies.
    Genuardi JS; Stiller JM; Trapnell GR
    Health Care Financ Rev; 1996; 17(3):191-204. PubMed ID: 10158730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.